BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Wednesday reported fourth-quarter net income of $12.3 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Beverly Hills, California-based company said it had net income of 42 cents. Losses, adjusted for non-recurring gains, were 11 cents per share.
The biotechnology company posted revenue of $475,800 in the period. Its adjusted revenue was $476,000.
For the year, the company reported net income of $2.4 million, or 9 cents per share, swinging to a profit in the period. Revenue was reported as $2.7 million.
In the final minutes of trading on Wednesday, the company's shares hit $1.81. A year ago, they were trading at $3.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR